No products in the cart.
Cat:GMP-h-HABP
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Genemedi produces core diagnostic ingredients for test of Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis) and related syndrome. GeneMedi offers paired diagnostics grade Hyaluronic acid binding protein (HABP) antibodies (monoclonal antibody, mab) and antigens for Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis) rapid test kit of Hyaluronic acid binding protein (HABP) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Hyaluronic acid is an unbranched glycosaminoglycan, a single chain of polymers of disaccharide units
containing N-acetylhexosamine and hexose.1 Hyaluronic acid is widely distributed in connective tissue
and produced mainly in mesenchymal cells.2 Hyaluronic acid has several functions, e.g. lubrication in
joints, prevention from bacterial invasion and internal body hydration.
Hyaluronic acid is the best marker to date for serially assessing liver cirrhosis. Serum concentration of
HA is consistent with stage of fibrosis, and also decreases with a response to interferon therapy in
patients with HCV chronic infection
Hyaluronic acid binding protein is used to quantitatively determine the Hyaluronic Acid (HA) in Serum and Plasma
Product Description
Cat No. of Pruducts
GMP-h-HABP-Ag01:Recombinant Human HABP Protein
Product Name
Recombinant Human HABP Protein
Target
Hyaluronic acid binding protein
Alias of Target/Biomarker
#N/A
Expression platform
E.coli
Isotypes
Recombinant Antigen
Bioactivity validation
Hyaluronic acid binding protein (HABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HABP level test of Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis) and related syndrome evaluation
Tag
His
Products description
Recombinant Human HABP Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Previous slide
Next slide
Cat No. of Pruducts
GMP-h-HABP-Ab01,GMP-h-HABP-Ab02:Anti-Human HABP mouse monoclonal antibody (mAb)
Product Name
Anti-Human HABP mouse monoclonal antibody (mAb)
Target
Hyaluronic acid binding protein (HABP)
Alias of Target/Biomarker
#N/A
Expression platform
Hybridoma
Isotypes
Mouse IgG
Bioactivity validation
Human Hyaluronic acid binding protein (HABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hyaluronic acid binding protein (HABP) antibodies in HABP level test of Liver diseases (rheumatoid arthritis?(RA) andosteoarthritis) and related syndrome evaluation.
Tag
mFc
Products description
Anti-Human HABP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hyaluronic acid binding protein (HABP) antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1
Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
